PQA Home PQA Home Phone (703) 690-1987
Contact Us Online
"Optimizing Patients' Health by Improving the Quality of Medication Use"
HOME ABOUT PQA ACADEMIC MEASURES MEMBERSHIP MDTs and SAPs RESOURCES
 
PQA Measure Development



PQA Newsletter



 
Pharmacy Quality Alliance

6213 Old Keene Mill Court
Springfield, VA   22152

Phone: (703) 690-1987
Fax: (703) 842-8150

To contact us, email:
info@pqaalliance.org
or click here.


PQA Measure Development Teams and Task Forces



The 2017 Measure Development Team (MDTs) and Task Forces (TFs) are listed below, and include those that are new measure concepts for development in 2017, as well as concepts continuing from 2016: 

MDT / TF Title / Description
MDT 9
  • MTM: Medication Therapy Problem Resolution
MDT 12
  • Inappropriate Duplicate Therapy
MDT 14
  • MTM: Next Generation MTM Measure
IZ TF 2
  • IZ Status Assessment within MTM
  • ACIP Compliance Following IZ Status Assessment within MTM
IZ TF 3
  • ACIP Schedule Completion in Patients with Diabetes
MS TF
  • Use of DMT in Persons with Relapsing Forms of MS
  • MRI Prior to Initiating or Switching DMT in Patients with Relapsing Forms of MS
  • MRI to Establish a New Baseline After Initiating or Switching DMT in Patients with Relapsing Forms of MS
  • MRI for Follow-Up in Patients with Relapsing Forms of MS Being Treated with DMT



























ACIP = Advisory Committee on Immunization Practices; DMT = Disease Modifying Therapy; 
IZ = Immunization; MDT = Measure Development Team; MTM = Medication Therapy Management; MRI = Magnetic Resonance Imaging; MS = Multiple Sclerosis; TF = Task Force

 


2017 MDT Application Schedule

Applications submitted by                 January 26, 2017

Notification of selection status          February 2, 2017

Term begins                                      February 3, 2017



 
© Copyright 2017 Pharmacy Quality Alliance | Site Development & Hosting By ISADEX Corporation | Connections | Terms | Privacy Visit Us On Facebook      Visit Us On Twitter      Visit Us On LinkedIn